Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Blueprint Medicines Corp.
DescriptionInhibitor of ret proto-oncogene (RET)
Molecular Target Ret proto-oncogene (RET)
Mechanism of ActionRET inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today